Top players in biosimulation market operating are Certara (US), Simulation Plus (US), Dassault Systèmes (France), Schrödinger (US), ACD/Labs (Canada), Chemical Computing Group (Canada), Physiomics (UK), Evidera (US), In silico biosciences (US), INOSIM Software (Germany), Insilico Biotechnology (Germany), LeadInvent Technologies (India), Rosa (US), Nuventra Pharma (US), and Genedata (Switzerland).
- Advertising -
Download the Brochure of Biosimulation Market report with 149 market data Tables with 57 Figures across 318 Pages and in-depth TOC at www.rnrmarketresearch.com/contacts…mple?rname=398116 .
Biosimulation market is projected to reach USD 2.88 Billion by 2022 from USD 1.38 Billion in 2017, at a CAGR of 15.9%. Factors like increase in R&D investments in pharmaceutical & biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery & development costs, & growth in biologics and biosimilars markets are driving growth of market.
Target Audience for Biosimulation Market Report:
- Biosimulation product manufacturers, vendors, and distributors
- Market research and consulting companies
- Regulatory authorities
- Associations related to pharmaceutical and biotechnology research
- Biotechnology and pharmaceutical companies
- Academic and government research institutes
- Contract research organizations (CROs)
The biosimulation market is segmented into software and services.
- Advertising -
The biosimulation services segment is projected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the recurring need for services such as data analysis, and consulting services.
Biosimulation Market Report with Top Trends, Forecast, Analysis and Overview at www.rnrmarketresearch.com/contacts/?rname=398116 .
North America is expected to account for the largest share of the market followed by Europe. However, Europe is expected to register the highest CAGR during the forecast period.
The growing focus on research-related funding activities by governments is expected to assist in the development of drug discovery and development process, thus driving the demand for biosimulation in European region.
Biosimulation Market by Software
- Molecular Modeling and Simulation Software
- PBPK Modeling and Simulation Software
- PK/PD Modeling and Simulation Software
- Trial Design Software
- Toxicity Prediction Software
Biosimulation Market By End User
- Pharmaceutical and Biotechnology Companies
- Research Institutes
- Contract Research Organizations
- Regulatory Authorities
Study estimates biosimulation market size for 2017 & projects its demand till 2022. In primary research process, various sources from both demand side & supply side were interviewed to obtain qualitative and quantitative information for report.
Primary sources from demand side include various industry CEOs, vice presidents, marketing directors, technology & innovation directors, & related key executives from various players in biosimulation market.
Report at www.rnrmarketresearch.com/contacts/398116 .
1 Biosimulation Market Overview
2 Biosimulation Software Market, By Type
3 Geographic Analysis: Biosimulation Market in Europe, By End User and Country
4 Biosimulation Drug Developement Market, By Type
Biosimulation market report will help stakeholders to understand competitive landscape better & gain insights to position their businesses & help companies make suitable go-to-market strategies. Report also helps stakeholders understand pulse of market & provide them with information regarding key market drivers & opportunities.
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: